HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2D- and 3D-QSAR studies on 54 anti-tumor Rubiaceae-type cyclopeptides.

Abstract
RA-VII, a bicyclic hexapeptide isolated from the roots of Rubia cordifolia, Rubia akane belongs to Rubiaceae-type cyclopeptides (RAs) and has attracted much attention for its potent anti-tumor activity and its bicyclic structure incorporating the isodityrosine moiety. In this work, hologram quantitative structure-activity relationship (HQSAR), comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis (CoMSIA) methods were employed to develop 2D- and 3D-QSAR models for 54 anti-tumor RAs. The LOO cross-validated q(2) values of HQSAR, CoMFA and CoMSIA models are 0.701, 0.510 and 0.613, respectively. The predictive ability of these models was validated by the test set including 7 RAs, and the predicted IC(50) values were in good agreement with the experimental IC(50) values. HQSAR result showed that chirality descriptor plays an important role in anti-tumor activity of RAs and OMe at R(1) and R(2) is necessary for increasing their activity. CoMFA and CoMSIA results demonstrated that small bulky and electropositive side chains at R(3) position and hydrophobic groups at R(7) and R(8) positions will increase their activity, and intra-molecular hydrogen bonds between residues 1 and 4 are necessary to maintain the pharmacophoric conformation of RAs. These results may be helpful in designing novel and potential anti-tumor RAs.
AuthorsHe Yan, Xulin Pan, Ninghua Tan, Junting Fan, Guangzhi Zeng, Hongjin Han
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 44 Issue 9 Pg. 3425-32 (Sep 2009) ISSN: 1768-3254 [Electronic] France
PMID19303172 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Peptides, Cyclic
  • RA VII
Topics
  • Antineoplastic Agents (chemistry, pharmacology)
  • Computer Simulation
  • Models, Molecular
  • Peptides, Cyclic (chemistry, pharmacology)
  • Quantitative Structure-Activity Relationship
  • Rubia (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: